VCY1B: The Basic Protein on the Y Chromosome 1 (G353513)

Target Name: VCY1B

NCBI ID: G353513

VCY1B

VCY1B: The Basic Protein on the Y Chromosome 1

Introduction

The Y chromosome is the only sex chromosome that a male possesses. It plays a vital role in the development and reproduction of males, and it is home to many essential proteins that are involved in various cellular processes. One of these proteins is VCY1B, which is a basic protein that is located on the Y chromosome.

VCY1B is a small protein that is made up of only 18 amino acids. It has a molecular weight of 19.3 kDa and a pre-calculated pI of 12.9. VCY1B is a protein that is expressed in almost all human tissues, including muscle, heart, brain, andtestes. It is also highly conserved, with only one difference at amino acid position 62.

VCY1B's Structure and Function

The structure of VCY1B is very conserved, with only one difference at amino acid position 62. It has a characteristic alpha-helices and a distinct N-terminus. The protein has a length of 19.3 kDa and a calculated pI of 12.9.

VCY1B is a basic protein that is involved in various cellular processes. One of its functions is to act as a signaling protein. It can interact with various signaling proteins, including the and T-cell signaling pathways.

VCY1B is also involved in the regulation of gene expression. It has been shown to play a role in the regulation of gene expression in various tissues, including muscle and heart.

VCY1B is also involved in the regulation of cellular signaling pathways. It can interact with various signaling proteins, including the T-cell signaling pathway.

VCY1B is a potential drug target

The conservation of VCY1B's structure and function make it an attractive drug target. Many studies have suggested that VCY1B may be a drug target that can be targeted with small molecules or antibodies.

One of the potential benefits of targeting VCY1B is that it can be used to treat a variety of diseases that are caused by the over-expression of genes. For example, VCY1B has been shown to be involved in the regulation of gene expression in various tissues , including muscle and heart. Targeting VCY1B may be a way to treat conditions such as heart failure, muscle dystrophy, and cancer.

Another potential benefit of targeting VCY1B is that it is a basic protein that is involved in the regulation of many cellular processes. This makes it an attractive target for drugs that are designed to modulate cellular signaling pathways.

VCY1B is a potential biomarker

VCY1B is also a potential biomarker for several diseases. The conservation of its structure and function makes it an attractive target for diagnostic tests.

For example, VCY1B has been shown to be involved in the regulation of gene expression in various tissues, including muscle and heart. This makes it an attractive target for diagnostic tests that are designed to detect changes in gene expression.

VCY1B has also been shown to be involved in the regulation of cellular signaling pathways. This makes it an attractive target for diagnostic tests that are designed to detect changes in cellular signaling pathways.

Conclusion

VCY1B is a basic protein that is located on the Y chromosome. It is involved in various cellular processes and has been shown to play a role in the regulation of gene expression and cellular signaling pathways. As a result, it is an attractive drug target and a potential biomarker for several diseases. Further research is needed to fully understand the role of VCY1B in cellular processes and its potential as a drug or biomarker.

Protein Name: Variable Charge Y-linked 1B

Functions: May mediate a process in spermatogenesis or may play a role in sex ratio distortion

The "VCY1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VCY1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets